Kidney in Coronavirus Disease 2019 Registry

Launched by UNIVERSITY OF COLOGNE · Mar 11, 2021

Keywords

ClinConnect Summary

The "Kidney in Coronavirus Disease 2019 Registry" is a clinical trial aimed at understanding how COVID-19, caused by the SARS-CoV-2 virus, affects the kidneys in patients. Researchers have noticed that some patients with COVID-19 experience serious kidney problems, which can lead to severe health issues and even death. This study wants to gather more information about these kidney problems to help develop better treatments for COVID-19 in the future.

To be eligible for the trial, participants need to have a confirmed SARS-CoV-2 infection, either through a test or other medical evidence. The study is open to all ages and genders. Participants will be part of a larger group that researchers will study to learn more about the costs and outcomes of COVID-19 related to kidney injuries. If you join, you can expect to provide information about your health and experience, contributing to important research that could improve care for patients with COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Virology evidence of SARS-CoV-2-infection
• • Pathological evidence of SARS-CoV-2-infection
• Exclusion Criteria:
• • Occurrence of ARDS (acute respiratory distress syndrome) without evidence of SARS-CoV-2 infection
• • Acute kidney injury without evidence of SARS-CoV-2 infection